BIM
IBB icon

Bridges Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Bridges Investment Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-4,866
Closed -$423K – 133
2016
Q1 		$423K Buy
4,866
+30
+0.6% +$2.68K 0.08% 100
2015
Q4 		$545K Buy
+4,836
New +$525K 0.1% 95

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
SG
Societe Generale $14.1B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bridges Investment Management's IBB Position: Q2 2016 in Review

Bridges Investment Management sold out of iShares Biotechnology ETF (IBB) in Q2 2016, closing a stake of 4,866 shares — an estimated $423K sold.

Bridges Investment Management first reported a position in IBB in Q4 2015 and held it in 2 quarters. The position peaked at $545K in Q4 2015. 428 funds tracked by Wall St. Rank hold IBB as of Q2 2016.

  • Bridges Investment Management reported no remaining iShares Biotechnology ETF position as of Q2 2016 after selling out during the quarter.
  • Bridges Investment Management sold 4,866 iShares Biotechnology ETF shares in Q2 2016, an estimated $423K.
  • Bridges Investment Management first reported a position in iShares Biotechnology ETF in Q4 2015 and held it in 2 quarters.
  • Bridges Investment Management's iShares Biotechnology ETF position peaked at $545K in Q4 2015.
  • 428 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2016.

Based on Bridges Investment Management's 13F filing for Q2 2016, filed 6 Jul 2016.